dc.contributor.author | Rubio Carrasquilla, Marcela | |
dc.contributor.author | Cano Restrepo, Luz Elena | |
dc.contributor.author | Moreno Frías, Ernesto | |
dc.date | 2023-01-16 | |
dc.date.accessioned | 2023-01-16T21:18:09Z | |
dc.date.available | 2023-01-16T21:18:09Z | |
dc.identifier.uri | http://hdl.handle.net/11407/7661 | |
dc.description | HistoFerón: primer ensayo diagnóstico para la detección de infección latente por un hongo patogénico. Es un libro que propone una nueva prueba diagnóstica llamada HistoFerón, para detectar infecciones subclínicas o latentes por Histoplasma capsulatum (Hc), incluso décadas después de la infección primaria. Estas infecciones pueden llegar a desarrollar formas clínicas graves en individuos con su sistema inmune debilitado y no son cubiertas por las pruebas de laboratorio que se aplican actualmente en la práctica clínica. Los temas abordados en el libro y el lenguaje utilizado conducen al lector a través de la epidemiología, la inmunología, y la amplia gama de formas clínicas de la histoplasmosis y su diagnóstico en el laboratorio. Se describen también las estrategias computacionales y experimentales que nos permitieron crear un prototipo del ensayo de liberación de interferón gamma específico para Histoplasma capsulatum, útil para los clínicos que tratan a pacientes vulnerables con alto riesgo de desarrollar una enfermedad grave. Se trata entonces de un reto científico y médico de mucha actualidad, y una línea de investigación apasionante. | spa |
dc.format.extent | 128 | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.publisher | Sello Editorial Universidad de Medellín | spa |
dc.subject | Hongos patógenos | spa |
dc.subject | Histoplasmosis | spa |
dc.subject | Diagnóstico de laboratorio | spa |
dc.subject | Pruebas clínicas | spa |
dc.subject | Interferón | spa |
dc.subject | Antígenos | spa |
dc.title | HistoFerón: primer ensayo diagnóstico para la detección de infección latente por un hongo patogénico | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.publisher.program | Derecho | spa |
dc.identifier.ddc | 616.969 | spa |
dc.identifier.doi | 10.22395/9789585180420 | |
dc.audience | General interest | spa |
dc.publisher.faculty | Facultad de Derecho | spa |
dc.format.spage | 1 | spa |
dc.format.epage | 128 | spa |
dc.audience.spa | Interés general | spa |
dc.rights.local | Acceso abierto | spa |
dc.relation.references | Aagaard, C., Brock, I., Olsen, A., Ottenhoff, T. H. M., Weldingh, K., y Andersen, P. (2004). Mapping Immune Reactivity toward Rv2653 and Rv2654: Two Novel Low‐Molecular‐Mass Antigens Found Specifically in the Mycobacterium tuber- culosis Complex. The Journal of Infectious Diseases, 189(5), 812–819. https:// doi.org/10.1086/381679 | |
dc.relation.references | Abate, D., Saldan, A., Forner, G., Tinto, D., Bianchin, A., y Palu, G. (2014). Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants. Journal of Virological Methods, 196. https://doi.org/10.1016/j.jviromet.2013.10.036 | |
dc.relation.references | Adenis, A. A., Valdes, A., Cropet, C., McCotter, O. Z., Derado, G., Couppie, P., … Nacher, M. (2018). Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. The Lancet Infectious Diseases, 3099(18), 1–10. https://doi.org/10.1016/S1473-3099(18)30354-2 | |
dc.relation.references | Aidé, M. A. (2009). Chapter 4--histoplasmosis. Jornal Brasileiro de Pneumologia : Pu-
blicaça o Oficial Da Sociedade Brasileira de Pneumologia e Tisilogia, 35(11),
1145–1151. https://doi.org/10.1590/S1806-37132009001100013 | |
dc.relation.references | Allendoerfer, R., y Deepe, G. S. (1998). Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. Journal of Immunology, 160(12), 6072–6082. https://doi.org/10.4049/jimmu- nol.176.3.1806 | |
dc.relation.references | Allendoerfer, R., y Deepe, G. S. (1997). Intrapulmonary response to Histoplasma cap- sulatum in gamma interferon knockout mice. Infection and Immunity, 65(7), 2564–2569. https://doi.org/9199420 | |
dc.relation.references | Allendoerfer, R., Maresca, B., y Deepe, G. S. (1996). Cellular immune responses to re- combinant heat shock protein 70 from Histoplasma capsulatum. Infection and Immunity, 64(10). https://doi.org/10.1128/iai.64.10.4123-4128.1996 | |
dc.relation.references | Allendörfer, R., Brunner, G. D., y Deepe, G. S. J. (1999). Complex requirements for nas- cent and memory immunity in pulmonary histoplasmosis. Journal of Immunology, 162(12), 7389–7396. https://doi.org/10358191 | |
dc.relation.references | Almeida, M. A., Baeza, L. C., Almeida-Paes, R., Bailão, A. M., Borges, C. L., Guimarães,
A. J., … Zancopé-Oliveira, R. M. (2021). Comparative Proteomic Analysis of His- toplasma capsulatum Yeast and Mycelium Reveals Differential Metabolic Shifts and Cell Wall Remodeling Processes in the Different Morphotypes. Frontiers in Microbiology, 12. https://doi.org/10.3389/fmicb.2021.640931 | |
dc.relation.references | Andersen, P., Munk, M. E., Pollock, J. M., y Doherty, T. M. (2000). Specific immune-ba- sed diagnosis of tuberculosis. Lancet (London, England), 356(9235), 1099–1104. https://doi.org/10.1016/S0140-6736(00)02742-2 | |
dc.relation.references | Arango-Bustamante, K., Restrepo, A., Cano, L. E., De Bedout, C., Tobón, A. M., y Gon- zález, A. (2013). Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. American Journal of Tropical Medicine and Hygiene, 89(5), 937–942. https://doi.org/10.4269/ajt- mh.13-0117 | |
dc.relation.references | Arango, M., Castañeda, E., Agudelo, C. I., De Bedout, C., Agudelo, C. A., Tobón, A., … Restrepo, A. (2011). Histoplasmosis: results of the Colombian national survey, 1992-2008. Biomédica : Revista Del Instituto Nacional de Salud, 31(3), 344–356. https://doi.org/10.1590/S0120-41572011000300007 | |
dc.relation.references | Aravalli, R. N., Hu, S., Woods, J. P., y Lokensgard, J. R. (2008). Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling. Journal of Neuroinflammation, 5. https://doi.org/10.1186/1742-2094-5-30 | |
dc.relation.references | Arend, S. M., Geluk, A., Meijgaarden, K. E. V. A. N., Jaap, T., Theisen, M., Andersen, P., y Ottenhoff, T. O. M. H. M. (2000). Antigenic Equivalence of Human T-Cell Res- ponses to Mycobacterium tuberculosis -Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic Peptides. Infection and Immunity, 68(6), 3314–3321. https://doi.org/10.1128/IAI.68.6.3314- 3321.2000.Updated | |
dc.relation.references | Arend, S. M., Thijsen, S. F. T., Leyten, E. M. S., Bouwman, J. J. M., Franken, W. P. J., Kos- ter, B. F. P. J., … Bossink, A. W. J. (2007). Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. American Journal of Respiratory and Critical Care Medicine, 175(6), 618–627. https://doi.org/10.1164/ rccm.200608-1099OC | |
dc.relation.references | Armstrong, P. A., Beard, J. D., Bonilla, L., Arboleda, N., Lindsley, M. D., Chae, S.-R.,
… Vallabhaneni, S. (2017). Outbreak of Severe Histoplasmosis Among Tunnel Workers—Dominican Republic, 2015. Clinical Infectious Diseases. https://doi. org/10.1093/cid/cix1067 | |
dc.relation.references | Ashbee, H. R., Evans, E. G. V., Viviani, M. A., Dupont, B., Chryssanthou, E., Surmont, I., … Tintelnot, K. (2008). Histoplasmosis in Europe: Report on an epidemiologi- cal survey from the european confederation of medical mycology working group. Medical Mycology, 46(1), 57–65. https://doi.org/10.1080/13693780701591481 | |
dc.relation.references | Azar, M. M., y Hage, C. A. (2017a). Clinical Perspectives in the Diagnosis and Manage- ment of Histoplasmosis. Clinics in Chest Medicine, 38(3), 403–415. https://doi. org/10.1016/j.ccm.2017.04.004 | |
dc.relation.references | Azar, M. M., y Hage, C. A. (2017b). Laboratory Diagnostics for Histoplasmosis. Journal of Clinical Microbiology, 55(6), 1612–1620. | |
dc.relation.references | Azuma, I., Kanetsuna, F., Tanaka, Y., Yamamura, Y., y Carbonell, L. M. (1974). Chemi- cal and immunological properties of galactomannans obtained from Histoplasma duboisii, Histoplasma capsulatum, Paracoccidioides brasiliensis and Blasomyces dermatitidis. Mycopathologia et Mycologia Applicata, 54(1), 111–125. https://doi. org/10.1007/BF02055979 | |
dc.relation.references | Barcellini, L., Borroni, E., Brown, J., Brunetti, E., Codecasa, L., Cugnata, F., … Cirillo,
D. M. (2016). First independent evaluation of QuantiFERON-TB Plus performan- ce. European Respiratory Journal. https://doi.org/10.1183/13993003.02033-2015 | |
dc.relation.references | Barth, R. E., Mudrikova, T., y Hoepelman, A. I. M. (2008). Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics?. Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. International Journal of Infectious Diseases, 12(6). https://doi.org/10.1016/j.ijid.2008.03.026 | |
dc.relation.references | Bartu, V., Havelkova, M., y Kopecka, E. (2008). QuantiFERON®-TB Gold in the Diag- nosis of Active Tuberculosis. Journal of International Medical Research, 36(3), 434–437. https://doi.org/10.1177/147323000803600307 | |
dc.relation.references | Basso, R. P., Poester, V. R., Benelli, J. L., Stevens, D. A., Zogbi, H. E., Vasconcellos, I. C. da S., … Xavier, M. O. (2021). COVID-19-Associated Histoplasmosis in an AIDS Patient. Mycopathologia, 186(1). https://doi.org/10.1007/s11046-020-00505-1 | |
dc.relation.references | Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G., y Brunak, S. (2004). Feature-based prediction of non-classical and leaderless protein secretion. Protein Engineering, Design and Selection, 17(4), 349–356. https://doi.org/10.1093/protein/gzh037 | |
dc.relation.references | Benedict, K., y Mody, R. K. (2016). Epidemiology of histoplasmosis outbreaks, United States, 1938-2013. Emerging Infectious Diseases, 22(3), 370–378. https://doi. org/10.3201/eid2203.151117 | |
dc.relation.references | Bonifaz, A., Vázquez-González, D., y Perusquía-Ortiz, A. M. (2011). Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blas- tomycosis. JDDG - Journal of the German Society of Dermatology, 9(9), 705–716. https://doi.org/10.1111/j.1610-0387.2011.07731.x | |
dc.relation.references | Borgström, E., Andersen, P., Atterfelt, F., Julander, I., Källenius, G., Maeurer, M., … Gaines, H. (2012). Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promi- sing Marker. PLoS ONE, 7(11), 1–10. https://doi.org/10.1371/journal.pone.0043438 | |
dc.relation.references | Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., y Wiley, D. C. (1993). Three-dimensional structure of the human class II histocom- patibility antigen HLA-DR1. Nature, 364(6432). https://doi.org/10.1038/364033a0 | |
dc.relation.references | Bullock, W. E., y Wright, S. D. (1987). Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macro- phages. The Journal of Experimental Medicine, 165(1), 195–210. https://doi. org/10.1084/jem.165.1.195 | |
dc.relation.references | Cáceres, D. H., Gómez, B. L., Restrepo, Á., y Tobón, Á. M. (2012). Histoplasmosis y sida: factores de riesgo clínicos y de laboratorio asociados al pronóstico de la enferme- dad. Infectio, 16(Supl 3), 44–50. https://doi.org/10.1016/S0123-9392(12)70026-7 | |
dc.relation.references | Caceres, D. H., Knuth, M., Derado, G., y Lindsley, M. D. (2019). Diagnosis of progressive disseminated histoplasmosis in advanced HIV: A meta-analysis of assay analyti- cal performance. Journal of Fungi, 5(3). https://doi.org/10.3390/jof5030076 | |
dc.relation.references | Cáceres, D. H., Samayoa, B. E., Medina, N. G., Tobón, A. M., Guzmán, B. J., Mercado, D.,
… Gómez, B. L. (2018). Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV/ AIDS in two Latin American countries. Journal of Clinical Microbiology, 56(6). https://doi.org/10.1128/JCM.01959-17 | |
dc.relation.references | Cain, J. A., y Deepe, G. S. (2000). Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum. Infection and Immunity, 68(4), 2069–2076. https://doi.org/10.1128/IAI.68.4.2069-2076.2000 | |
dc.relation.references | Cardona, N. I., Moncada, D. M., y Gómez-Marin, J. E. (2015). A rational approach to select immunogenic peptides that induce IFN-γ response against Toxoplasma gondii in human leukocytes. Immunobiology, 220(12), 1337–1342. https://doi. org/10.1016/j.imbio.2015.07.009 | |
dc.relation.references | Carmona FJ. (1971). Análisis estadístico y ecológico-epidemiológico de la sensibilidad a la histoplasmina en Colombia 1950-1968. Antioquia Médica, 21(2), 100–154. | |
dc.relation.references | Carr, J., y Shearer, G. (1998). Genome size, complexity, and ploidy of the pathogenic fungus Histoplasma capsulatum. Journal of Bacteriology, 180(24). https://doi. org/10.1128/jb.180.24.6697-6703.1998 | |
dc.relation.references | Chapey, E., Wallon, M., Debize, G., Rabilloud, M., y Peyron, F. (2010). Diagnosis of con- genital toxoplasmosis by using a whole-blood gamma interferon release assay. Journal of Clinical Microbiology, 48(1), 41–45. https://doi.org/10.1128/JCM.01903- 09 | |
dc.relation.references | Chastain, D. B., Henao-Martínez, A. F., y Franco-Paredes, C. (2017). Opportunistic In- vasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis,and Talaromycosis. Current Infectious Disease Reports. https://doi.org/10.1007/ s11908-017-0592-7 | |
dc.relation.references | Chaves, F. A., Lee, A. H., Nayak, J. L., Richards, K. A., y Sant, A. J. (2012). The Uti- lity and Limitations of Current Web-Available Algorithms To Predict Peptides Recognized by CD4 T Cells in Response to Pathogen Infection. The Journal of Immunology, 188(9). https://doi.org/10.4049/jimmunol.1103640 | |
dc.relation.references | Choi, J. C., Shin, J. W., Kim, J. Y., Park, I. W., Choi, B. W., y Lee, M. K. (2008). The effect of previous tuberculin skin test on the follow-up examination of whole-blood in- terferon-γ assay in the screening for latent tuberculosis infection. Chest, 133(6), 1415–1420. https://doi.org/10.1378/chest.07-2193 | |
dc.relation.references | Coady, A., y Sil, A. (2015). MyD88-dependent signaling drives host survival and ear- ly cytokine production during Histoplasma capsulatum infection. Infection and Immunity, 83(4), 1265–1275. https://doi.org/10.1128/IAI.02619-14 | |
dc.relation.references | Colombo, A. L., Tobón, A., Restrepo, A., Queiroz-Telles, F., y Nucci, M. (2011). Epidemio- logy of endemic systemic fungal infections in Latin America. Medical Mycology. https://doi.org/10.3109/13693786.2011.577821 | |
dc.relation.references | Cong, H., Mui, E. J., Witola, W. H., Sidney, J., Alexander, J., Sette, A., … McLeod, R. (2011). Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine, 29(4), 754–762. https://doi.org/10.1016/j.vaccine.2010.11.015 | |
dc.relation.references | Cottle, L. E., Gkrania-Klotsas, E., Williams, H. J., Brindle, H. E., Carmichael, A. J., Fry, G., y Beeching, N. J. (2013). A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. Journal of Travel Medicine, 20(2), 83–87. https://doi.org/10.1111/jtm.12012 | |
dc.relation.references | Dammermann, W., Bentzien, F., Stiel, E. M., Kühne, C., Ullrich, S., zur Wiesch, J. S., y Lüth, S. (2015). Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients. Journal of Trans- lational Medicine, 13(1). https://doi.org/10.1186/s12967-015-0513-1 | |
dc.relation.references | Darling, S. T. (1908). Histoplasmosis: A Fatal Infectious Disease Resembling Kala-Azar Found Among Natives of Tropical America. Archives of Internal Medicine, 2(2), 107–123. https://doi.org/10.1001/archinte.1908.00050070002001 | |
dc.relation.references | Deepe Jr., G. S., y McGuinness, M. (2006). Interleukin-1 and host control of pulmonary histoplasmosis. J Infect Dis, 194(6), 855–864. https://doi.org/10.1086/506946 | |
dc.relation.references | Deepe, G. S., y Durose, G. G. (1995). Immunobiological activity of recombinant H an- tigen from Histoplasma capsulatum. Infection and Immunity, 63(8), 3151–3157. | |
dc.relation.references | Deepe, George S. (2014). Histoplasma capsulatum (Histoplasmosis). In Mandell, Dou- glas, and Bennett’s Principles and Practice of Infectious Diseases (Vol. 2, pp. 2949–2962). https://doi.org/10.1016/B978-1-4557-4801-3.00265-4 | |
dc.relation.references | Deepe, George S, y Gibbons, R. (2001). Protective Efficacy of H Antigen from Histoplas- ma capsulatum in a Murine Model of Pulmonary Histoplasmosis. Infection and Immunity, 69(5), 3128–3134. https://doi.org/10.1128/IAI.69.5.3128 | |
dc.relation.references | Deepe, George S, y Gibbons, R. S. (2009). Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. The Journal of Infectious Diseases, 200(1), 142–151. https://doi.org/10.1086/599333 | |
dc.relation.references | del Corral, H., Paris, S. C., Marin, N. D., Marin, D. M., Lopez, L., Henao, H. M., … Gar- cia, L. F. (2009). IFNγ response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One, 4(12), e8257. https://doi.org/10.1371/journal.pone.0008257 | |
dc.relation.references | Díaz G., C. (2008). Mecanismos de Acción de los Fármacos Inmunosupresores. Revista Chilena de Reumatología, 24(2), 73–88. | |
dc.relation.references | Dominguez, M. R., Silveira, E. L. V, de Vasconcelos, J. R. C., de Alencar, B. C. G., Ma- chado, A. V, Bruna-Romero, O., … Rodrigues, M. M. (2011). Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite. PloS One, 6(7), 1–12. https://doi.org/10.1371/jour- nal.pone.0022011 | |
dc.relation.references | Dunlap, N. E., Bass, J., Fujiwara, P., Hopewell, P., Horsburgh, C. R., Salfinger, M., & Simone, P. M. (2000). Diagnostic standards and classification of tuberculosis in adults and children. American Journal of Respiratory and Critical Care Medici- ne. https://doi.org/10.1164/ajrccm.161.4.16141 | |
dc.relation.references | Dye, C., Scheele, S., Dolin, P., Pathania, V., y Raviglione, M. C. (1999). Consensus sta- tement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Jama, 282(7), 677–686. https://doi.org/10.1001/jama.282.7.677 | |
dc.relation.references | Edwards, J. A., Alore, E. A., y Rappleye, C. A. (2011). The yeast-phase virulence require- ment for α-glucan synthase differs among histoplasma capsulatum chemotypes. Eukaryotic Cell, 10(1), 87–97. https://doi.org/10.1128/EC.00214-10 | |
dc.relation.references | Edwards, J. A., Chen, C., Kemski, M. M., Hu, J., Mitchell, T. K., y Rappleye, C. A. (2013). Histoplasma yeast and mycelial transcriptomes reveal pathogenic-phase and lineage-specific gene expression profiles. BMC Genomics, 14(1), 1. https://doi. org/10.1186/1471-2164-14-695 | |
dc.relation.references | Emanuelsson, O., Nielsen, H., Brunak, S., y von Heijne, G. (2000). Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. Journal of Molecular Biology, 300(4), 1005–1016. https://doi.org/10.1006/jmbi.2000.3903 | |
dc.relation.references | Emmons CW. (1949). Isolation of Histoplasma capsulatum from soil. Public Health Rep., 64(28), 892–896. https://doi.org/10.1001/archpedi.1932.01950130232022 | |
dc.relation.references | Eum, S. Y., Lee, Y. J., Kwak, H. K., Min, J. H., Hwang, S. H., Via, L. E., … Cho, S. N.
(2008). Evaluation of the diagnostic utility of a whole-blood interferon-γ assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calme- tte-Guerin (BCG)-vaccinated individuals. Diagnostic Microbiology and Infectious Disease, 61(2), 181–186. https://doi.org/10.1016/j.diagmicrobio.2008.01.002 | |
dc.relation.references | Ewer, K., Millington, K. A., Deeks, J. J., Alvarez, L., Bryant, G., y Lalvani, A. (2006). Dynamic antigen-specific T-cell responses after point-source exposure to My- cobacterium tuberculosis. American Journal of Respiratory and Critical Care Medicine, 174(7), 831–839. https://doi.org/10.1164/rccm.200511-1783OC | |
dc.relation.references | Fernandez-Andreu, C. M., Cadre-Raton, A. M., Maciin, G. M., Hernandez, A. L., y Her- nandez, M. S. (1994). Relación entre la prueba intradérmica de histoplasmina y los niveles de anticuerpos detectables por ELISA e inmunodifusión. Rev. Ins. Med.Trop. São Paulo, 36 (1), 83–87. | |
dc.relation.references | Fojtasek, M. F., Sherman, M. R., Garringer, T., Blair, R., Wheat, L. J., y Schnizlein- Bick,
C. T. (1993). Local immunity in lung-associated lymph nodes in a murine mo- del of pulmonary histoplasmosis. Infection and Immunity, 61(11), 4607–4614. | |
dc.relation.references | Gascón, J., Torres, J. M., Jiménez, M., Mejias, T., Triviño, L., Gobbi, F., … Corachan, M. (2005). Histoplasmosis infection in Spanish travelers to Latin America. Euro- pean Journal of Clinical Microbiology and Infectious Diseases, 24(12), 839–841. https://doi.org/10.1007/s10096-005-0050-6 | |
dc.relation.references | Getahun, H., Matteelli, A., Chaisson, R. E., y Raviglione, M. (2015). Latent Mycobacterium tuberculosis Infection. New England Journal of Medicine, 372(22), 2127–2135. https://doi.org/10.1056/NEJMra1405427 | |
dc.relation.references | Gidwani, K., Jones, S., Kumar, R., Boelaert, M., y Sundar, S. (2011). Interferon-Gamma release assay (modified quantiFERON) as a potential marker of infection for Lei- shmania donovani, a proof of concept study. PLoS Neglected Tropical Diseases, 5(4). https://doi.org/10.1371/journal.pntd.0001042 | |
dc.relation.references | Gildea, L. A., Ciraolo, G. M., Morris, R. E., y Newman, S. L. (2005). Human dendritic cell activity against Histoplasma capsulatum is mediated via phagolysosomal fusion. Infection and Immunity, 73(10), 6803–6811. https://doi.org/10.1128/ IAI.73.10.6803-6811.2005 | |
dc.relation.references | Giulieri, S., y Manuel, O. (2011). QuantiFERON®-CMV assay for the assessment of cy- tomegalovirus cell-mediated immunity. Expert Review of Molecular Diagnostics. https://doi.org/10.1586/erm.10.109 | |
dc.relation.references | Gómez, A. M., Rhodes, J. C., y Deepe, G. S. (1991). Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infection and Immunity, 59(1), 330–336. | |
dc.relation.references | Gomez, F. J., Allendoerfer, R., y Deepe Jr, G. S. (1995). Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infection and Immunity, 63(7), 2587. Retrieved from http://www. ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstrac- tPlus&list_uids=7911197207696073954related:4mTJ8PE3ym0J%5Cnhttp:// www.ncbi.nlm.nih.gov/pmc/articles/PMC173347/pdf/632587.pdf | |
dc.relation.references | Gomez, F. J., Gomez, A. M., y Deepe, G. S. (1992). An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces ce- ll-mediated immune responses and protection in mice. Infection and Immunity, 60(7), 2565–2571. http://www.pubmedcentral.nih.gov/articlerender.fcgi?arti- d=257204&tool=pmcentrez&rendertype=abstract | |
dc.relation.references | Gómez, L. F., Torres, I. P., Jiménez, M. D. P., McEwen, J. G., de Bedout, C., Peláez, C. A.,
… Arango, M. (2018a). Detection ofHistoplasma capsulatumin Organic Fertili- zers by Hc100 Nested Polymerase Chain Reaction and Its Correlation with the Physicochemical and Microbiological Characteristics of the Samples. The Ame- rican Journal of Tropical Medicine and Hygiene, 1–20. https://doi.org/10.4269/ ajtmh.17-0214 | |
dc.relation.references | Gómez, L. F., Torres, I. P., Jiménez, M. D. P., McEwen, J. G., de Bedout, C., Peláez, C. A.,
… Arango, M. (2018b). Detection ofHistoplasma capsulatumin Organic Fertilizers by Hc100 Nested Polymerase Chain Reaction and Its Correlation with the Phy- sicochemical and Microbiological Characteristics of the Samples. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.17-0214 | |
dc.relation.references | Goodwin, R. A., Loyd, J. E., y Des Prez, R. M. (1981). Histoplasmosis in normal hosts. Medicine (United States), 60(4), 231–266. https://doi.org/10.1097/00005792-198107000-00001 | |
dc.relation.references | Gourraud, P. A., Khankhanian, P., Cereb, N., Yang, S. Y., Feolo, M., Maiers, M., … Oksen- berg, J. (2014). HLA diversity in the 1000 genomes dataset. PLoS ONE, 9(7). https://doi.org/10.1371/journal.pone.0097282 | |
dc.relation.references | Green, J. H., Harrell, W. K., Gray, S. B., Johnson, J. E., Bolin, R. C., Gross, H., y Mal- colm, G. B. (1976). H and M antigens of Histoplasma capsulatum: preparation of antisera and location of these antigens in yeast-phase cells. Infect Immun, 14(3), 826–831. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&- db=PubMed&dopt=Citation&list_uids=965099 | |
dc.relation.references | Guedes, H. L. D. M., Guimarães, A. J., Muniz, M. D. M., Pizzini, C. V., Hamilton, A. J., Peralta, J. M., … Zancopé-Oliveira, R. M. (2003). PCR assay for identification of histoplasma capsulatum based on the nucleotide sequence of the M antigen. Jour- nal of Clinical Microbiology, 41(2), 535–539. https://doi.org/10.1128/JCM.41.2.535 | |
dc.relation.references | Guimaraes, A. J., Frases, S., Gomez, F. J., Zancope-Oliveira, R. M., y Nosanchuk, J. D. (2009). Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of histoplasma capsulatum. Infection and Immunity, 77, 1357–1367. https://doi. org/10.1128/IAI.01443-08 | |
dc.relation.references | Guimarães, Allan J., Martinez, L. R., y Nosanchuk, J. D. (2011). Passive administration of monoclonal antibodies against H. capsulatum and others fungal pathogens. Journal of Visualized Experiments, (48), 1–6. https://doi.org/10.3791/2532 | |
dc.relation.references | Guimarães, Allan Jefferson, Hamilton, A. J., de M. Guedes, H. L., Nosanchuk, J. D., y Zancopé-Oliveira, R. M. (2008). Biological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum. PLoS ONE, 3(10), 1–17. https:// doi.org/10.1371/journal.pone.0003449 | |
dc.relation.references | Guimarães, Allan Jefferson, Nosanchuk, J. D., y Maria, Z.-O. R. (2006). Diagnosis of Histoplasmosis. Braz J Microbiol., 37(1), 1–13. | |
dc.relation.references | Guimarães, Allan Jefferson, Pizzini, C. V., De Matos Guedes, H. L., Albuquerque, P. C., Peralta, J. M., Hamilton, A. J., y Zancopé-Oliveira, R. M. (2004). ELISA for ear- ly diagnosis of histoplasmosis. Journal of Medical Microbiology, 53(6), 509–514. https://doi.org/10.1099/jmm.0.05469-0 | |
dc.relation.references | Habich, C., Kempe, K., Gomez, F. J., Lillicrap, M., Gaston, H., van der Zee, R., … Burkart,
V. (2006). Heat shock protein 60: identification of specific epitopes for binding to primary macrophages. FEBS Letters, 580(1), 115–120. https://doi.org/10.1016/j. febslet.2005.11.060 | |
dc.relation.references | Hage, C. A., Azar, M. M., Bahr, N., Loyd, J., y Wheat, L. J. (2015). Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management. Semi- nars in Respiratory and Critical Care Medicine, 36(5), 729–745. https://doi. org/10.1055/s-0035-1562899 | |
dc.relation.references | Hage, C. A., Davis, T. E., Fuller, D., Egan, L., Witt, J. R., Wheat, L. J., y Knox, K. S. (2010). Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest, 137(3), 623–628. https://doi.org/10.1378/chest.09-1702 | |
dc.relation.references | Hamilton, A. J., Bartholomew, M. A., Figueroa, J., Fenelon, L. E., y Hay, R. J. (1990). Evi- dence that the m antigen of histoplasma capsulatum var. Capsulatum is a catalase which exhibits Cross-reactivity with other dimorphic fungi. Medical Mycology, 28(6), 479–485. https://doi.org/10.1080/02681219080000601 | |
dc.relation.references | Harris, J. E., y Deepe, G. S. (1988). Characterization of antigenic determinants in histo- plasmin that stimulate Histoplasma capsulatum-reactive T cells in vitro. Infection and Immunity, 56(9), 2343–2349. | |
dc.relation.references | Hill, P. C., Brookes, R. H., Fox, A., Jackson-Sillah, D., Jeffries, D. J., Lugos, M. D., … McAdam, K. P. (2007). Longitudinal assessment of an ELISPOT test for Myco- bacterium tuberculosis infection. PLoS Medicine, 4(6), 1061–1070. https://doi. org/10.1371/journal.pmed.0040192 | |
dc.relation.references | Hober, D., Benyoucef, S., Chehadeh, W., De, G. D., De X, L. T., Mouton, Y., y Wattre, P. (2000). Ex vivo interferon-gamma response to human immunodefiency virus-1 derived peptides in human immunodeficiency virus-1 infected patients. Scand.J Immunol., 51(0300-9475 (Print)), 429–433. | |
dc.relation.references | Holbrook, E. D., Kemski, M. M., Richer, S. M., Wheat, L. J., y Rappleye, C. a. (2014). Gly- cosylation and immunoreactivity of the Histoplasma capsulatum Cfp4 yeast-phase exoantigen. Infection and Immunity, 82(10), 4414–4425. https://doi.org/10.1128/ IAI.01893-14 | |
dc.relation.references | Holbrook, E. D., y Rappleye, C. A. (2008). Histoplasma capsulatum pathogenesis: ma- king a lifestyle switch. Current Opinion in Microbiology, 11(4), 318–324. https:// doi.org/10.1016/j.mib.2008.05.010 | |
dc.relation.references | Horwath, M. C., Fecher, R. A., y Deepe, G. S. (2015). Histoplasma capsulatum, lung in- fection and immunity. Future Microbiology, 10, 967–975. https://doi.org/10.2217/ fmb.15.25 | |
dc.relation.references | Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., … Niel- sen, M. (2018). Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology, 154(3). https://doi.org/10.1111/imm.12889 | |
dc.relation.references | Jiménez, R. A., Urán, M. E., de Bedout, C., Arango, M., Tobón, A. M., Cano, L. E., y Res- trepo, A. (2002). Outbreak of acute histoplasmosis in a family group: identification of the infection source. Biomédica: Revista Del Instituto Nacional de Salud, 22(2). https://doi.org/10.7705/biomedica.v22i2.1154 | |
dc.relation.references | Johnson, C. H., Klotz, M. G., York, J. L., Kruft, V., y McEwen, J. E. (2002). Redundan- cy, phylogeny and differential expression of Histoplasma capsulatum catalases. Microbiology, 148(4), 1129–1142. https://doi.org/10.1099/00221287-148-4-1129 | |
dc.relation.references | Kasuga, T., White, T. J., Koenig, G., Mcewen, J., Restrepo, A., Castañeda, E., ... Taylor, J. W. (2003). Phylogeography of the fungal pathogen Histoplasma capsulatum. Molecular Ecology, 12(12), 3383–3401. https://doi.org/10.1046/ j.1365-294X.2003.01995.x | |
dc.relation.references | Kauffman, C. A., Freifeld, A. G., Andes, D. R., Baddley, J. W., Herwaldt, L., Walker, R. C., … Pappas, P. G. (2014). Endemic fungal infections in solid organ and hemato- poietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transplant Infectious Disease, 16(2), 213– 224. https://doi.org/10.1111/tid.12186 | |
dc.relation.references | Kauffman, C.. (2007). Histoplasmosis: A clinical and laboratory update. Clinical Micro- biology Reviews. https://doi.org/10.1128/CMR.00027-06 | |
dc.relation.references | Kauffman, C. A. (2009). Histoplasmosis. Clinics in Chest Medicine. https://doi.or- g/10.1016/j.ccm.2009.02.002 | |
dc.relation.references | Kro, G., Asberg, A., Rollag, H., y Muller, F. (2017). Higher degree of CMV reactivation in CMV R+/ IGRA-than R+/IGRA+ renal transplant recipients. Transplant Interna- tional, 30(Supplement 2), 88–89. https://doi.org/http://dx.doi.org/10.1111/tri.13051 | |
dc.relation.references | Kroetz, D. N., y Deepe, G. S. (2012). The role of cytokines and chemokines in Histo- plasma capsulatum infection. Cytokine, 58(1), 112–117. https://doi.org/10.1016/j. cyto.2011.07.430 | |
dc.relation.references | Krogh, A., Larsson, B., von Heijne, G., y Sonnhammer, E. L. (2001). Predicting trans- membrane protein topology with a hidden Markov model: application to complete genomes. Journal of Molecular Biology, 305(3), 567–580. https://doi.org/10.1006/ jmbi.2000.4315 | |
dc.relation.references | Kurita, N., Terao, K., Brummer, E., Ito, E., Nishimura, K., y Miyaji, M. (1991). Resistance of Histoplasma capsulatum to killing by human neutrophils - Evasion of oxidative burst and lysosomal-fusion products. Mycopathologia, 115(3), 207–213. https:// doi.org/10.1007/BF00462229 | |
dc.relation.references | Kwon-Chung, K. J. (1972). Sexual stage of Histoplasma capsulatum. Science (New York, N.Y.), 175(19), 326. https://doi.org/10.1126/science.175.4019.326 | |
dc.relation.references | Lalvani, A. (2007). Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy. Chest, 131(6), 1898–1906. https://doi.org/10.1378/ chest.06-2471 | |
dc.relation.references | Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., Mcgettigan, P. A., McWilliam, H., … Higgins, D. G. (2007). Clustal W and Clustal X version 2.0. Bioinformatics, 23(21). https://doi.org/10.1093/bioinformatics/btm404 | |
dc.relation.references | Lee, J. H., Slifman, N. R., Gershon, S. K., Edwards, E. T., Schwieterman, W. D., Siegel, J. N., … Braun, M. M. (2002). Life-threatening histoplasmosis complicating immu- notherapy with tumor necrosis factor α antagonists infliximab and etanercept. Arthritis and Rheumatism, 46(10), 2565–2570. https://doi.org/10.1002/art.10583 | |
dc.relation.references | Lee, P. P., y Lau, Y. L. (2017). Cellular and molecular defects underlying invasive fungal infections-revelations from endemic mycoses. Frontiers in Immunology. https:// doi.org/10.3389/fimmu.2017.00735 | |
dc.relation.references | Lochmanova, A., Lochman, I., Tomaskova, H., Marsalkova, P., Raszka, J., Mrazek, J.,
… Brozmanova, H. (2010). Quantiferon-CMV test in prediction of cytomegalo- virus infection after kidney transplantation. Transplantation Proceedings, 42(9), 3574–3577. https://doi.org/10.1016/j.transproceed.2010.07.101 | |
dc.relation.references | Long, K. H., Gomez, F. J., Morris, R. E., y Newman, S. L. (2003). Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. Journal of Immunology (Baltimore, Md. : 1950), 170(1), 487–494. http://www.ncbi.nlm.nih.gov/pubmed/12496435 | |
dc.relation.references | Losi, M., Knights, A. J., Mariani, F., Altieri, A. M., Paone, G., Loxton, A. G., … Amicosante, M. (2016). QuantiFERON-TB performance enhanced by novel Myco- bacterium tuberculosisspecific antigens. European Respiratory Journal. https:// doi.org/10.1183/13993003.01015-2015 | |
dc.relation.references | Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., … Lange, C. (2009). LTBI: Latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. In European Respiratory Journal (pp. 956–973). https://doi.org/10.1183/09031936.00120908 | |
dc.relation.references | Marín, N. D., París, S. C., Rojas, M., y García, L. F. (2012). Reduced frequency of me- mory T cells and increased Th17 responses in patients with active tuberculosis. Clinical and Vaccine Immunology, 19(10), 1667–1676. https://doi.org/10.1128/ CVI.00390-12 | |
dc.relation.references | Markowitz, H. (1967). Antibodies in Histoplasmosis, 93(1), 40–46. | |
dc.relation.references | Mayfield, J. A., y Rine, J. (2007). The genetic basis of variation in susceptibility to in- fection with Histoplasma capsulatum in the mouse. Genes and Immunity, 8(6), 468–474. https://doi.org/10.1038/sj.gene.6364411 | |
dc.relation.references | Mazurek, G. H., Jereb, J., Lobue, P., Iademarco, M. F., Metchock, B., y Vernon, A. (2005). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports, 54(RR- 15), 49–55. | |
dc.relation.references | Mazurek, G. H., y Villarino, M. E. (2003). Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports / Centers for Disease Control, 52(RR-2), 15–18. | |
dc.relation.references | McKinsey, D. S., Spiegel, R. A., Hutwagner, L., Stanford, J., Driks, M. R., Brewer, J., … Dall, L. (1997). Prospective study of histoplasmosis in patients infected with hu- man immunodeficiency virus: incidence, risk factors, and pathophysiology. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 24(6), 1195–1203. https://doi.org/10.1086/513653 | |
dc.relation.references | Medeiros, A. I., Bonato, V. L. D., Malheiro, A., Dias, A. R. V., Silva, C. L., y Faccioli, L.
H. (2002). Histoplasma capsulatum inhibits apoptosis and Mac-1 expression in leucocytes. Scandinavian Journal of Immunology, 56(4), 392–398. https://doi. org/10.1046/j.1365-3083.2002.01142.x | |
dc.relation.references | Menzies, D. (1999). Interpretation of repeated tuberculin tests: Boosting, conversion, and reversion. American Journal of Respiratory and Critical Care Medicine. https:// doi.org/10.1164/ajrccm.159.1.9801120 | |
dc.relation.references | Messina, F. A., Marin, E., Caceres, D. H., Romero, M., Depardo, R., Priarone, M. M., … Santiso, G. (2020). Coronavirus disease 2019 (Covid-19) in a patient with dis- seminated histoplasmosis and hiv—a case report from argentina and literature review. Journal of Fungi, 6(4). https://doi.org/10.3390/jof6040275 | |
dc.relation.references | Mittal, J., Ponce, M. G., Gendlina, I., y Nosanchuk, J. D. (2019). Histoplasma capsulatum: Mechanisms for pathogenesis. In Current Topics in Microbiology and Immunolo- gy (Vol. 422). https://doi.org/10.1007/82_2018_114 | |
dc.relation.references | Morgan, J., Cano, M. V., Feikin, D. R., Phelan, M., Monroy, O. V., Morales, P. K., … Haj- jeh, R. A. (2003). A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001. American Journal of Tropical Medicine and Hygiene, 69(6), 663–669. | |
dc.relation.references | Muraille, E., Leo, O., y Moser, M. (2014). Th1/Th2 paradigm extended: Macrophage po- larization as an unappreciated pathogen-driven escape mechanism? Frontiers in Immunology, 5(NOV), 1–12. https://doi.org/10.3389/fimmu.2014.00603 | |
dc.relation.references | Nagai, H., Suzukawa, M., Sakakibara, Y., Ohta, K., Reche, P. A., Suzuki, K., y Hoshino,
Y. (2014). Immunological Responses and Epitope Mapping by Tuberculosis-As- sociated Antigens within the RD1 Region in Japanese Patients, 2014. | |
dc.relation.references | Nanjappa, S. G., Heninger, E., Wüthrich, M., Gasper, D. J., y Klein, B. S. (2012). Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathogens, 8(7), 24. https://doi.org/10.1371/ journal.ppat.1002771 | |
dc.relation.references | Negroni, R., De Flores, C. I., y Robles, A. M. (1976). [Study of serologic cross reactions between the antigens of Paracoccidioides brasiliensis and Histoplasma capsula- tum]. Rev Asoc Argent Microbiol, 8(2), 68–73. | |
dc.relation.references | Nel, J. S., Bartelt, L. A., van Duin, D., y Lachiewicz, A. M. (2018). Endemic Mycoses in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America, 32(3), 667–685. https://doi.org/10.1016/j.idc.2018.04.007 | |
dc.relation.references | Newman, S. L., Gootee, L., y Gabay, J. E. (1993). Human neutrophil-mediated fungis- tasis against Histoplasma capsulatum: Localization of fungistatic activity to the azurophil granules. Journal of Clinical Investigation, 92(2), 624–631. https://doi. org/10.1172/JCI116630 | |
dc.relation.references | Newman, S. L., Gootee, L., Gabay, J. E., y Selsted, M. E. (2000). Identification of consti- tuents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum. Infection and Immunity, 68(10), 5668–5672. https:// doi.org/10.1128/IAI.68.10.5668-5672.2000 | |
dc.relation.references | Nielsen, M., y Andreatta, M. (2016). NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Genome Medicine, 8(1). https://doi.org/10.1186/s13073- 016-0288-x | |
dc.relation.references | Nosanchuk, J. (2005). Protective Antibodies and Endemic Dimorphic Fungi. Current Molecular Medicine, 5(4), 435–442. https://doi.org/10.2174/1566524054022530 | |
dc.relation.references | Nosanchuk, J. D., Zancopé-Oliveira, R. M., Hamilton, A. J., y Guimarães, A. J. (2012). Antibody therapy for histoplasmosis. Frontiers in Fungi and Their Interactions, 3(February), 21. https://doi.org/10.3389/fmicb.2012.00021 | |
dc.relation.references | Ohno, H., Ogata, Y., Suguro, H., Yokota, S., Watanabe, A., Kamei, K., … Miyazaki, Y. (2010). An outbreak of histoplasmosis among healthy young Japanese women after traveling to Southeast Asia. Internal Medicine (Tokyo, Japan), 49(5), 491–
495. https://doi.org/10.2169/internalmedicine.49.2759 | |
dc.relation.references | Olson, T. C., Bongartz, T., Crowson, C. S., Roberts, G. D., Orenstein, R., y Matteson, E.
L. (2011). Histoplasmosis infection in patients with rheumatoid arthritis, 1998- 2009. BMC Infectious Diseases, 11. https://doi.org/10.1186/1471-2334-11-145 | |
dc.relation.references | Ordóñez, N., Tobón, A., Arango, M., Tabares, A., De Bedout, C., Gómez, B., … Restrepo,
A. (1997). Brotes de histoplasmosis registrados en el área andina colombiana.
Biomédica, 17(2), 105. https://doi.org/10.7705/biomedica.v17i2.941 | |
dc.relation.references | Pai, M., Joshi, R., Dogra, S., Mendiratta, D. K., Narang, P., Kalantri, S., … Menzies,
D. (2006). Serial testing of health care workers for tuberculosis using interfe- ron-gamma assay. American Journal of Respiratory and Critical Care Medicine, 174(3), 349–355. https://doi.org/10.1164/rccm.200604-472OC | |
dc.relation.references | Pai, M., Joshi, R., Dogra, S., Zwerling, A. A., Gajalakshmi, D., Goswami, K., … Hopewell,
P. C. (2009). T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. International Journal of Tuberculosis and Lung Disease, 13(1), 84–92. | |
dc.relation.references | Patel, A. A., Swerlick, R. A., y McCall, C. O. (2006). Azathioprine in dermatology: The past, the present, and the future. Journal of the American Academy of Derma- tology. https://doi.org/10.1016/j.jaad.2005.07.059 | |
dc.relation.references | Patel, M., Lu, F., Hannaway, M., y Hochman, K. (2015). Fibrosing mediastinitis: a rare complication of histoplasmosis. BMJ Case Reports, 2015. https://doi.org/10.1136/ bcr-2015-212774 | |
dc.relation.references | Pauw, B. De, Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., … Bennett, J. E. (2008). Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious | |
dc.relation.references | Diseases Mycoses Study Group (EORTC/MSG) C. Clinical Infectious Diseases, 46,
1813–1821. https://doi.org/10.1086/588660 | |
dc.relation.references | Petersen, T. N., Brunak, S., von Heijne, G., y Nielsen, H. (2011). SignalP 4.0: discrimi- nating signal peptides from transmembrane regions. Nature Methods, 8(10), 785–786. https://doi.org/10.1038/nmeth.1701 | |
dc.relation.references | Petruccioli, E., Chiacchio, T., Pepponi, I., Vanini, V., Urso, R., Cuzzi, G., … Goletti, D. (2016). First characterization of the CD4 and CD8 T-cell responses to Quanti- FERON-TB Plus. Journal of Infection, 73(6), 588–597. https://doi.org/10.1016/j. jinf.2016.09.008 | |
dc.relation.references | Pieterman, E. D., Liqui Lung, F. G., Verbon, A., Bax, H. I., Ang, C. W., Berkhout, J., … de Steenwinkel, J. E. M. (2018). A multicentre verification study of the QuantiFE- RON®-TB Gold Plus assay. Tuberculosis, 108(September 2017), 136–142. https:// doi.org/10.1016/j.tube.2017.11.014 | |
dc.relation.references | Queiroz-Telles, F., Fahal, A. H., Falci, D. R., Caceres, D. H., Chiller, T., y Pasqualotto, A.
C. (2017). Neglected endemic mycoses. The Lancet Infectious Diseases, 17(11), e367–e377. https://doi.org/10.1016/S1473-3099(17)30306-7 | |
dc.relation.references | Ray, S. C., y Rappleye, C. A. (2018). Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition. Seminars in Cell and Developmental Biology, 1–8. https://doi.org/10.1016/j.semcdb.2018.03.009 | |
dc.relation.references | Reeves, M. W., Pine, L., Kaufman, L., y McLaughlin, D. (1972). Isolation of a new soluble antigen from the yeast phase of Histoplasma capsulatum. Applied Mi- crobiology, 24(5), 841–843. http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=380675&tool=pmcentrez&rendertype=abstract | |
dc.relation.references | Rodrigues, L. C., Secatto, A., Sorgi, C. A., Dejani, N. N., Medeiros, A. I., Prado, M. K. B., … Dias-Baruffi, M. (2016). Protective Effect of Galectin-1 during Histoplasma capsu- latum Infection Is Associated with Prostaglandin E2 and Nitric Oxide Modulation. Mediators of Inflammation, 2016, 5813794. https://doi.org/10.1155/2016/5813794 | |
dc.relation.references | Rubio-Carrasquilla, M., Ochoa, R., Santa, C., Guimarães, A. J., Cano, L. E., y Moreno,
E. (2019). Identifying molecularly defined antigens for a Histoplasma capsu- latum-specific interferon gamma release assay. Revista Iberoamericana de Micologia, 36(4). https://doi.org/10.1016/j.riam.2019.06.002 | |
dc.relation.references | Rubio-Carrasquilla, M., Santa, C. D., Rendón, J. P., Botero-Garcés, J., Guimarães, A. J., Moreno, E., y Cano, L. E. (2019). An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: A proof of concept study. Medical Mycology, 57(6). https://doi.org/10.1093/mmy/myy131 | |
dc.relation.references | Rutledge, T. F., Boyd, M. F., Mazurek, M., Jereb, J., Vernon, A., LoBue, P., … Cdc, C. for D. C. and P. (2010). Updated guidelines for using Interferon Gamma Relea- se Assays to detect Mycobacterium tuberculosis infection - United States, 2010. | |
dc.relation.references | MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report Recommendations and Reports / Centers for Disease Control, 59(RR-5), 1–25. https://doi.org/rr5415a4 [pii] | |
dc.relation.references | Sá-Nunes, A., Medeiros, A. I., Nicolete, R., Frantz, F. G., Panunto-Castelo, A., Silva, C. L., y Faccioli, L. H. (2005). Efficacy of cell-free antigens in evaluating cell immu- nity and inducing protection in a murine model of histoplasmosis. Microbes and Infection, 7(4), 584–592. https://doi.org/10.1016/j.micinf.2004.12.017 | |
dc.relation.references | Saldan, A., Forner, G., Mengoli, C., Tinto, D., Fallico, L., Peracchi, M., … Abate, D. (2016). Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and cmv quantiFERON cell-mediated immune assays in CMV-seropositive and
-seronegative pregnant and nonpregnant women. Journal of Clinical Microbio- logy, 54(5), 1376–1380. https://doi.org/10.1128/JCM.03128-15 | |
dc.relation.references | Salomon, J., Flament Saillour, M., De Truchis, P., Bougnoux, M. E., Dromer, F., Dupont, B., … Perronne, C. (2003). An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West Indies. J Travel Med, 10(2), 87–93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d- b=PubMed&dopt=Citation&list_uids=12650650 | |
dc.relation.references | Salvin, S. B. (1959). Current concepts of diagnostic serology and skin hypersensitivi- ty in the mycoses. The American Journal of Medicine, 27(1), 97–114. https://doi. org/10.1016/0002-9343(59)90064-6 | |
dc.relation.references | Sathapatayavongs, B., Batteiger, B. E., Wheat, J., Slama, T. G., y Wass, J. L. (1983). Cli- nical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore), 62(5), 263–270. Retrieved from http:// www.ncbi.nlm.nih.gov/pubmed/6312246 | |
dc.relation.references | Scheel, C. M., Samayoa, B., Herrera, A., Lindsley, M. D., Benjamin, L., Reed, Y., … Gomez, B. L. (2009). Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients. Clin Vaccine Immunol, 16(6), 852–858. https://doi.org/CVI.00066-09 [pii]\r10.1128/CVI.00066-09 | |
dc.relation.references | Scully, M. C., & Baddley, J. W. (2018). Epidemiology of Histoplasmosis. Current Fungal Infection Reports, pp. 1–8. https://doi.org/10.1007/s12281-018-0309-x | |
dc.relation.references | Segel, M. J., Rozenman, J., Lindsley, M. D., Lachish, T., Berkman, N., Neuberger, A., y Schwartz, E. (2015). Histoplasmosis in Israeli travelers. American Journal of Tropical Medicine and Hygiene, 92(6), 1168–1172. https://doi.org/10.4269/ ajtmh.14-0509 | |
dc.relation.references | Sepúlveda, V. E., Márquez, R., Turissini, D. A., Goldman, W. E., y Matute, D. R. (2017). Genome sequences reveal cryptic speciation in the human pathogen Histoplas- ma capsulatum. MBio, 8(6). https://doi.org/10.1128/mBio.01339-17 | |
dc.relation.references | Sester, M., Sotgiu, G., Lange, C., Giehl, C., Girardi, E., Migliori, G. B., … Manissero, D. (2011). Interferon-γ release assays for the diagnosis of active tuberculosis: A sys- tematic review and meta-analysis. European Respiratory Journal, 37(1), 100–111. https://doi.org/10.1183/09031936.00114810 | |
dc.relation.references | Shar L. Waldrop, Christine J. Pitcher, Dolores M. Peterson, Vernon C. Maino, y L. J. P. (1997). Determination of Antigen-specific Memory / Effector CD4 + T Cell Frequencies by Flow Cytometry. The Journal of Clinical Investigation, 99(7), 1739–1750. | |
dc.relation.references | Shi, L., Albuquerque, P. C., Lazar-Molnar, E., Wang, X., Santambrogio, L., Gácser, A., y Nosanchuk, J. D. (2008). A monoclonal antibody to Histoplasma capsulatum al- ters the intracellular fate of the fungus in murine macrophages. Eukaryotic Cell, 7(7), 1109–1117. https://doi.org/10.1128/EC.00036-08 | |
dc.relation.references | Sifuentes-Osornio, J., Corzo-León, D. E., y Ponce-De-León, L. A. (2012). Epidemiology of invasive fungal infections in Latin America. Current Fungal Infection Reports, 6, 23–34. https://doi.org/10.1007/s12281-011-0081-7 | |
dc.relation.references | Tagmouti, S., Slater, M., Benedetti, A., Kik, S. V., Banaei, N., Cattamanchi, A., … Den- kinger, C. (2014). Reproducibility of interferon gamma (IFN-γ) release assays a systematic review. Annals of the American Thoracic Society, 11(8), 1267–1276. https://doi.org/10.1513/AnnalsATS.201405-188OC | |
dc.relation.references | Taylor, A. L., Watson, C. J. E., y Bradley, J. A. (2005). Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Critical Re- views in Oncology/Hematology, 56(1 SPEC. ISS.), 23–46. https://doi.org/10.1016/j. critrevonc.2005.03.012 | |
dc.relation.references | Teixeira, M. de M., Patané, J. S. L., Taylor, M. L., Gómez, B. L., Theodoro, R. C., de Hoog, S., … Barker, B. M. (2016). Worldwide Phylogenetic Distributions and Population Dynamics of the Genus Histoplasma. PLoS Neglected Tropical Diseases, 10(6), 1–20. https://doi.org/10.1371/journal.pntd.0004732 | |
dc.relation.references | Tenenberg, D. J., y Arden Howell. (1948). COMPLEMENT FIXATION TEST FOR HIS-TOPLASMOSIS. Public Health Reports, 63(6), 163–199. | |
dc.relation.references | Tobon, A. M., Agudelo, C. A., Rosero, D. S., Ochoa, J. E., Bedout, C., Zuluaga, A., … Am, J. T. M. H. (2005). Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunode- ficiency virus-infected individuals. Am J Trop Med Hyg, 73(3), 576–582. https:// doi.org/73/3/576 [pii] | |
dc.relation.references | Smith, J. G., Liu, X., Kaufhold, R. M., Clair, J., y Caulfield, M. J. (2001). Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clinical and Diagnostic Laboratory Immunology. https://doi.org/10.1128/CDLI.8.5.871-879.2001 | |
dc.relation.references | Toyotome, T., Watanabe, A., Ochiai, E., y Kamei, K. (2015). N-acetylated α-linked acidic dipeptidase is identified as an antigen of Histoplasma capsulatum. Biochemical and Biophysical Research Communications, 458(3), 483– 487. https://doi. org/10.1016/j.bbrc.2015.01.129 | |
dc.relation.references | Travassos, L. R., y Taborda, C. P. (2017). Linear epitopes of Paracoccidioides brasiliensis and other fungal agents of human systemic mycoses as vaccine candidates. Fron- tiers in Immunology, 8(MAR), 1–11. https://doi.org/10.3389/fimmu.2017.00224 | |
dc.relation.references | Tsiodras, S., Samonis, G., Boumpas, D. T., y Kontoyiannis, D. P. (2008). Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clinic Procee- dings. Mayo Clinic, 83(2), 181–194. https://doi.org/10.4065/83.2.181 | |
dc.relation.references | Turgay, N., Balcioglu, I. C., Toz, S. O., Ozbel, Y., y Jones, S. L. (2010). Short report: Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection. American Journal of Tropical Medicine and Hygiene, 83(4), 822–824. https://doi.org/10.4269/ajtmh.2010.09-0605 | |
dc.relation.references | Vallabhaneni, S., y Chiller, T. M. (2016). Fungal Infections and New Biologic Thera- pies. Current Rheumatology Reports. https://doi.org/10.1007/s11926-016-0572-1 | |
dc.relation.references | Van Prooyen, N., Henderson, C. A., Hocking Murray, D., y Sil, A. (2016). CD103+ Con- ventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans. PLoS Patho- gens, 12(7), 1–16. https://doi.org/10.1371/journal.ppat.1005749 | |
dc.relation.references | Vergidis, P., Avery, R. K., Wheat, L. J., Dotson, J. L., Assi, M. A., Antoun, S. A., … Hage, C. A. (2015). Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 61(3), 409–417. https://doi.org/10.1093/cid/civ299 | |
dc.relation.references | Weir, R. E., Morgan, A. R., Britton, W. J., Butlin, C. R., y Dockrell, H. M. (1994). Develo- pment of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. Journal of Immu- nological Methods, 176(1), 93–101. https://doi.org/10.1016/0022-1759(94)90353-0 | |
dc.relation.references | Wheat, J. (1995). Endemic mycoses in AIDS: A clinical review. Clinical Microbiology Reviews. | |
dc.relation.references | Wheat, J., French, M. L. V, Kamel, S., y Tewari, R. P. (1986). Evaluation of cross-reac- tions in Histoplasma capsulatum serologic tests. Journal of Clinical Microbiology, 23(3), 493–499. | |
dc.relation.references | Wheat, L. J. (1993). The role of the serologic diagnostic laboratory and the diagnosis of fungal disease. Fungal Diseases of the Lung. 2d Ed. New York: Raven, 29-38. | |
dc.relation.references | Wheat, L. J. (2001). Laboratory diagnosis of histoplasmosis: Update 2000. Seminars in Respiratory Infections. https://doi.org/10.1053/srin.2001.24243 | |
dc.relation.references | Wheat, L J., Azar, M. M., Bahr, N. C., Spec, A., Relich, R. F., y Hage, C. (2016). Histo- plasmosis. Infectious Disease Clinics of North America, 30(1), 207–227. https:// doi.org/10.1016/j.idc.2015.10.009 | |
dc.relation.references | Whitworth, H. S., Scott, M., Connell, D. W., Dongés, B., y Lalvani, A. (2013). IGRAs - The gateway to T cell based TB diagnosis. Methods, 61(1), 52–62. https://doi. org/10.1016/j.ymeth.2012.12.012 | |
dc.relation.references | Winters, M. S., Chan, Q., Caruso, J. A., y Deepe, G. S. (2010). Metallomic analysis of macrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses. The Journal of Infectious Diseases, 202(7), 1136–1145. https://doi.org/10.1086/656191 | |
dc.relation.references | Wood, P. R., Corner, L. A., y Plackett, P. (1990). Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of gamma inter- feron. Research in Veterinary Science, 49(1), 46–49. Retrieved from http://www. ncbi.nlm.nih.gov/pubmed/2116655 | |
dc.relation.references | Woods, J. P. (2016). Revisiting old friends: Developments in understanding Histoplas- ma capsulatum pathogenesis. Journal of Microbiology. https://doi.org/10.1007/ s12275-016-6044-5 | |
dc.relation.references | Wu, S.-Y., Yu, J.-S., Liu, F.-T., Miaw, S.-C., y Wu-Hsieh, B. A. (2013). Galectin-3 Negatively Regulates Dendritic Cell Production of IL-23/IL-17-Axis Cytokines in Infection by Histoplasma capsulatum. The Journal of Immunology, 190(7), 3427–3437. https://doi.org/10.4049/jimmunol.1202122 | |
dc.relation.references | Zámocký, M., y Koller, F. (1999). Understanding the structure and function of catalases: Clues from molecular evolution and in vitro mutagenesis. Progress in Biophysics and Molecular Biology. https://doi.org/10.1016/S0079-6107(98)00058-3 | |
dc.relation.references | Zancopé-Oliveira, R., Bragg, S. L., Hurst, S. F., Peralta, J. M., y Reiss, E. (1993). Evalua- tion of Cation Exchange Chromatography for the Isolation of M-glycoprotein from Histoplasmin. Journal of Medical and Veterinary Mycology, 31, 29–41. | |
dc.relation.references | Zancopé-Oliveira, R. M., Reiss, E., Lott, T. J., Mayer, L. W., Deepe, G. S. J., y Infect, I. (1999). Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun, 67(4), 1947–1953. | |
dc.type.local | Libro | spa |
dc.type.driver | info:eu-repo/semantics/book | spa |